RadBone: bone toxicity following pelvic radiotherapy – a prospective randomised controlled feasibility study evaluating a musculoskeletal health package in women with gynaecological cancers undergoing pelvic radiotherapy
Main Authors: | Janelle Yorke, Sarah O’Connell, Sally Taylor, Karen Johnson, Robert G Bristow, Martin Eden, Kate Haslett, John Moore, Rohit Kochhar, Victoria Chatzimavridou Grigoriadou, Lisa H Barraclough, Ivona Baricevic-Jones, Zoe Merchant, Thomas Westwood, Anthony David Whetton, Claire E Higham |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/12/6/e056600.full |
Similar Items
-
Radiotherapy-related insufficiency fractures and bone mineral density: what is the connection?
by: Victoria Chatzimavridou-Grigoriadou, et al.
Published: (2023-06-01) -
Upright patient positioning for pelvic radiotherapy treatments
by: S. Boisbouvier, et al.
Published: (2022-12-01) -
Reporting rectal dose in pelvic radiotherapy: Valid or virtual?
by: Chaitali M Waghmare
Published: (2023-01-01) -
Simple immobilization for stereotactic radiotherapy aimed at pelvic metastases
by: Jorinde Janssen, et al.
Published: (2023-07-01) -
Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study
by: Mathilde Baré, et al.
Published: (2022-07-01)